| My Account | Subscribe | Contact Us | Donate |
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Related Complications & Care Threads on Diabetes Health Forums
Results from a landmark study involving more than 9,000 people showed that the high blood pressure medicine valsartan (Diovan) delayed progression to type 2 diabetes in patients with cardiovascular disease or risk factors and impaired glucose tolerance (IGT), a common pre-diabetic condition.
0 comments - Mar 20, 2010 -
According to Duke University researchers, a mutation that causes the lack of an insulin-controlling molecule may be a factor in the development of type 2 diabetes. The molecule, ankyrin B, is activated in response to the smell and taste of food and leads to the production of insulin in preparation for food intake.
1 comment - Mar 19, 2010 -
Dear Diabetes Health, I am a 55-year-old man who was diagnosed with type 2 diabetes two years ago, and I think it made me depressed. The depression eventually got so bad that I didn't want to get out of bed in the morning. My doctor referred me to the psych clinic, where they put me on Paxil (paroxetine). The medication is helping my depression, but ruining my sex life. Basically, I can't get an erection, but I don't really care because I'm not interested anyway. I have no desire. My wife is still interested, however, and she is really upset about my lack of desire for sex. I don't like hurting her, and I don't want us to break up over this, but the depression was awful. I don't want to go back to that. What can I do?
1 comment - Mar 16, 2010 -
A university study of 20,000 Chinese adults aged 50 and older says that people who nap four to six days a week have a higher rate of type 2 diabetes than people who either never take a daily snooze or do so less often.
2 comments - Mar 10, 2010 -
The study started out with nearly 20,000 trim middle-aged and older women. Over time, women who drank alcohol in moderation put on less weight and were less apt to become overweight compared to non-drinkers. This was true even after taking into account various lifestyle and dietary factors that might influence a woman's weight.
2 comments - Mar 9, 2010 -
A U.S. Senate Finance Committee report released on February 20 says that Avandia, GlaxoSmithKline's drug for type 2 diabetes, may have caused as many as 83,000 heart attacks between 1999, when the drug was introduced, and 2007. The Senate report, culminating a two-year inquiry into the drug, also says that Glaxo knew about the drug's potential risks years before suspicions began to form regarding a connection between Avandia and heart problems.
2 comments - Feb 22, 2010 -
Thwarting a protein that carries an otherwise benign enzyme into the nuclei of cells in the retina, where the enzyme kills the retinal cells, may hold the key to preventing blindness in patients with diabetes. That's the conclusion of a two-year study by researchers at Michigan State University seeking a way to treat retinopathy, the disease that often leads to blindness in people with diabetes.
0 comments - Feb 16, 2010 -
A university survey of 92 doctors and their 1,200 patients who have diabetes and hypertension shows that the two groups don't always agree on which conditions are the most important to manage. The survey, conducted by the University of Michigan Medical School, asked doctors and patients to rank their top treatment priorities. While 38 percent of the doctors ranked treating hypertension as the most important, only 18 percent of their diabetes patients gave it the same ranking. Instead, diabetes patients are more likely to list pain and depression as the most important targets for treatment. In fact, the patients suffering the most from those conditions were the most likely to list them as priorities.
0 comments - Feb 16, 2010 -
Results of a 22-year study by researchers at Cardiff University School of Medicine in Wales indicate that older type 2s who try too hard to drive their A1c's down to "normal" (4.5% to 6%) may significantly increase their chances of early death. In fact, the study, just published in the British medical journal The Lancet*, found that type 2s with the lowest risk of death had A1c's of 7.5% -- a figure that few authorities on the disease have recommended as ideal.
14 comments - Feb 11, 2010 -
White fat is the "bad" gut fat associated with obesity and enlarged abdomens. When a pound of new white fat forms in the body, it requires a full mile of new blood vessels to nourish and sustain it. That's because white fat is much like a tumor in requiring a steady blood supply. To build the new blood vessels, it depends on a process called angiogenesis.
0 comments - Feb 8, 2010 -